Literature DB >> 16442532

Interaction of metallothionein with tumor suppressor p53 protein.

Elena A Ostrakhovitch1, Per-Erik Olsson, Sean Jiang, M George Cherian.   

Abstract

Previous reports have shown that metallothionein (MT) may modulate p53 activity through zinc exchange. However, little is known on a direct interaction between MT and p53 in cells. The results demonstrate an interaction between MT and p53 can occur in vitro. The complex between MT and p53 was observed in breast cancer epithelial cells with both wild and inactive type of p53. Furthermore, it was shown that wt-p53 was preferentially associated with Apo-MT. Our data suggest that co-expression of MT and p53 and their complex formation in tumor cells may be involved in regulation of apoptosis in these cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16442532     DOI: 10.1016/j.febslet.2006.01.036

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  19 in total

Review 1.  Zinc and zinc-containing biomolecules in childhood brain tumors.

Authors:  Jan Hrabeta; Tomas Eckschlager; Marie Stiborova; Zbynek Heger; Sona Krizkova; Vojtech Adam
Journal:  J Mol Med (Berl)       Date:  2016-09-16       Impact factor: 4.599

2.  Genome plasticity in response to stress in Tetrahymena thermophila: selective and reversible chromosome amplification and paralogous expansion of metallothionein genes.

Authors:  Patricia de Francisco; Ana Martín-González; Aaron P Turkewitz; Juan Carlos Gutiérrez
Journal:  Environ Microbiol       Date:  2018-05-22       Impact factor: 5.491

3.  Circulating monocytes in HIV-1-infected viremic subjects exhibit an antiapoptosis gene signature and virus- and host-mediated apoptosis resistance.

Authors:  Malavika S Giri; Michael Nebozyhn; Andrea Raymond; Bethsebah Gekonge; Aidan Hancock; Shenoa Creer; Calen Nicols; Malik Yousef; Andrea S Foulkes; Karam Mounzer; Jane Shull; Guido Silvestri; Jay Kostman; Ronald G Collman; Louise Showe; Luis J Montaner
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

Review 4.  A Correlation Between Intracellular Zinc Content and Osteosarcoma.

Authors:  Azadeh Meshkini
Journal:  Biol Trace Elem Res       Date:  2020-11-04       Impact factor: 3.738

5.  Effect of HPV on tumor expression levels of the most commonly used markers in HNSCC.

Authors:  Hana Polanska; Zbynek Heger; Jaromir Gumulec; Martina Raudenska; Marketa Svobodova; Jan Balvan; Michaela Fojtu; Hana Binkova; Zuzana Horakova; Rom Kostrica; Vojtech Adam; Rene Kizek; Michal Masarik
Journal:  Tumour Biol       Date:  2015-12-14

6.  Serum metallothioneins in childhood tumours-a potential prognostic marker.

Authors:  Jarmila Kruseova; David Hynek; Vojtech Adam; Rene Kizek; Richard Prusa; Jan Hrabeta; Tomas Eckschlager
Journal:  Int J Mol Sci       Date:  2013-06-06       Impact factor: 5.923

7.  Zinc chelation: a metallothionein 2A's mechanism of action involved in osteosarcoma cell death and chemotherapy resistance.

Authors:  N Habel; Z Hamidouche; I Girault; A Patiño-García; F Lecanda; P J Marie; O Fromigué
Journal:  Cell Death Dis       Date:  2013-10-24       Impact factor: 8.469

8.  The Balance between Life and Death of Cells: Roles of Metallothioneins.

Authors:  Allan Evald Nielsen; Adam Bohr; Milena Penkowa
Journal:  Biomark Insights       Date:  2007-02-07

9.  Identifying in-trans process associated genes in breast cancer by integrated analysis of copy number and expression data.

Authors:  Miriam Ragle Aure; Israel Steinfeld; Lars Oliver Baumbusch; Knut Liestøl; Doron Lipson; Sandra Nyberg; Bjørn Naume; Kristine Kleivi Sahlberg; Vessela N Kristensen; Anne-Lise Børresen-Dale; Ole Christian Lingjærde; Zohar Yakhini
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

10.  Analyzing M-CSF dependent monocyte/macrophage differentiation: expression modes and meta-modes derived from an independent component analysis.

Authors:  Dominik Lutter; Peter Ugocsai; Margot Grandl; Evelyn Orso; Fabian Theis; Elmar W Lang; Gerd Schmitz
Journal:  BMC Bioinformatics       Date:  2008-02-17       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.